Sunmax Biotechnology Co

Sunmax Biotechnology Co Current Ratio

The Current Ratio of Sunmax Biotechnology Co (4728.TWO) as of Nov 5, 2026 is 20.69. In the previous year, Current Ratio was 5.27 — a change of 292.90% (higher).

Current Ratio

20.69

YoY

292.90%

Last updated:

Current Ratio of Sunmax Biotechnology Co is 2025 20.69 . Current Ratio of Sunmax Biotechnology Co was 2024 5.27 . It decreases by 292.90% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunmax Biotechnology Co Stock analysis

What does Sunmax Biotechnology Co do? SunMax Biotechnology Co., Ltd. generates revenue through the development, manufacturing, and commercialization of medical devices, biomedical materials, and bio surgical products. Its major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, and medical collagen application equipment. These products are sold to customers in the medical and beauty care industries across Taiwan, Mainland China, and other regions. The company's distribution focuses on these key markets, leveraging its product portfolio for healthcare and aesthetic applications. The firm's product line targets both medical and beauty care sectors, with collagen-based solutions serving as core offerings. Medical collagen application equipment supports clinical procedures, while collagen implants and hemostat products address surgical and wound care needs. The company's presence in Taiwan, Mainland China, and other regions enables it to serve diverse healthcare markets with standardized product offerings. SunMax Biotechnology's revenue streams are derived from the sale of collagen-based medical devices and equipment, with a focus on applications in surgery, wound care, and aesthetic treatments. By distributing its products through established channels in Taiwan, Mainland China, and other regions, the company capitalizes on demand for biocompatible materials in healthcare and beauty care industries. Sunmax Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunmax Biotechnology Co stock

Current Ratio of Sunmax Biotechnology Co is 20.69 in 2025.

Current Ratio of Sunmax Biotechnology Co changed from 5.27 to 20.69, representing a 292.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Sunmax Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Sunmax Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Sunmax Biotechnology Co

All Key Metrics — Sunmax Biotechnology Co